Veraxa Biotech Holding AG (VRXAW) Cash & Current Investments (2024 - 2025)
Veraxa Biotech Holding AG (VRXAW) posted quarterly Cash & Current Investments of $1.5 million for Q4 2025, down 75.91% year-over-year from $6.3 million in Q4 2024, and down 75.91% quarter-over-quarter from $6.3 million in Q4 2024.
Veraxa Biotech Holding AG (VRXAW) Cash & Current Investments (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXAW) has reported Cash & Current Investments for 2 consecutive years, with $1.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash & Current Investments fell 75.91% year-over-year to $1.5 million; the TTM figure through Dec 2025 stood at $1.5 million (down 75.91% YoY), while the FY2025 annual figure was $1.5 million, down 75.91% from the prior year.
- Cash & Current Investments eased to $1.5 million in Q4 2025 per VRXAW's latest filing, from $6.3 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $6.3 million in Q4 2024 and bottomed at $1.5 million in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.52 Mn |
| Dec 31, 2024 | 6.30 Mn |